Riskpilot← Back to searchSign inGet full accessMedKon ApS
APSActiveCVR 43083163Jægersborg Alle 131Engineering activities and related technical consultancy · NACE 7112Est. 202223 employees
Revenue 2025
DKK 27,5M
+28% vs 2024
EBITDA margin
28.2%
+16% vs 2024
Equity ratio
45.1%
Financial strength
Net profit 2025
DKK 5,7M
+12% vs 2024
| Revenue | DKK 27,5M | +28% |
| EBITDA | DKK 7,8M | +16% |
| Net profit | DKK 5,7M | +12% |
| Total assets | DKK 17,4M | +21% |
| Equity | DKK 7,8M | +39% |
| Employees | 23 | — |
Legal name
MedKon ApS
CVR number
43083163
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
24. februar 2022
Share capital
DKK 40.000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen i forening
Company purpose
Selskabets formål er at drive virksomhed med handel og service, samt enhver i forbindelse hermed stående virksomhed.
Address
Jægersborg Alle 131
Email
mk@medkon.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 3.051 | 13.426 | 21.540 | 27.473 |
| Staff expenses | -1.935 | -9.116 | -14.858 | -19.720 |
| EBITDA | 1.116 | 4.310 | 6.682 | 7.753 |
| Depreciation & amort. | -3 | -23 | -52 | -207 |
| EBIT | 1.114 | 4.287 | 6.629 | 7.546 |
| Net financials | -1 | -1 | -30 | -9 |
| Profit before tax | 1.113 | 4.285 | 6.600 | 7.537 |
| Tax | 254 | 952 | 1.475 | 1.816 |
| Net profit | 859 | 3.334 | 5.125 | 5.721 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2.188 | 6.843 | 14.426 | 17.384 |
| Equity | 899 | 2.402 | 5.628 | 7.849 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1.287 | 4.436 | 8.754 | 9.497 |
| Total debt | 1.287 | 4.436 | 8.754 | 9.497 |
EBITDA margin
28.2%
This company
15.8%
Market median
+78% vs market
20222025
Equity ratio
45.1%
This company
38.2%
Market median
+18% vs market
20222025
Return on equity
72.9%
This company
18.4%
Market median
+296% vs market
20222025
Net profit margin
20.8%
This company
8.1%
Market median
+157% vs market
20222025
Asset turnover
1.58×
This company
1.12×
Market median
+41% vs market
20222025
Debt / equity
1.21×
This company
0.62×
Market median
-95% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-03-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JP Management | Management | 2023 |
ME Management | Management | 2022 |
MR Founder | Founder | 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2023 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2022 | |
| Company | 15–19.99% | 15–19.99% | 2023 | |
| Company | 10–14.99% | 10–14.99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jeansaha Holding ApS
MedKon ApS Board members of MedKon ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Petersen | Management | 0 companies |
| Milan Ellenger Kronborg | Management | 0 companies |
| Morten Reiff | Founder | 0 companies |